Russell Barton
Direttore operativo presso ACUMEN PHARMACEUTICALS, INC.
Patrimonio netto: 284 789 $ in data 31/05/2024
Profilo
Mr. Russell Barton is a Director-Clinical Operations at AgeneBio, Inc., a Chief Operating Officer at Acumen Pharmaceuticals, Inc. and a President & Consultant at Pharma Sagacity Consulting LLC.
Mr. Barton was previously employed as a Chief Operating Officer by Eli Lilly & Co. He received his undergraduate degree from Illinois State University and a graduate degree from Purdue University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 18/01/2024 | 96 867 ( 0.16% ) | 284 789 $ | 31/05/2024 |
Posizioni attive di Russell Barton
| Società | Posizione | Inizio |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Direttore operativo | 01/04/2019 |
AgeneBio, Inc.
 AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Direttore Tecnico/Scientifico/R&S | 01/10/2019 |
| Pharma Sagacity Consulting LLC | Presidente | 01/01/2018 |
Precedenti posizioni note di Russell Barton
| Società | Posizione | Fine |
|---|---|---|
| ELI LILLY AND COMPANY | Direttore operativo | - |
Formazione di Russell Barton
| Illinois State University | Undergraduate Degree |
| Purdue University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
| Pharma Sagacity Consulting LLC |
- Borsa valori
- Insiders
- Russell Barton
